Repetitive behavior disorders in autism

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 4, Issue 2, 1998, Pages 80-89

  Lewis, Mark H ^a   Bodfish, James W ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Western Carolina Center   (United States)

Author keywords

Akathisia; Basal ganglia; Compulsions; Dyskinesias; Self injury; Stereotypy; Tics

Indexed keywords

AKATHISIA; AUTISM; AUTOMUTILATION; CLINICAL FEATURE; COMPULSION; DISEASE ASSOCIATION; DYSKINESIA; HUMAN; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; STEREOTYPY; TIC;

EID: 0031879805     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2779(1998)4:2<80::AID-MRDD4>3.0.CO;2-0     Document Type: Review

References (115)

1. Allen L, Tejera C. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline. AmJ Psychiatry 1994;151:1096-1097.
2. Aman MG, Kern RA. Review of fenfluramine in the treatment of the developmental disabilities. J Am Acad Child Adolesc Psychiatry 1989;28:549-565.
3. Aman MG, White AJ, Field C. Chlorpromazine effects on Stereotypic and conditioned behaviour of severely retarded patients - a pilot study. J Ment Defic Res 1984;28:253-260.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
5. Angulo JA, McEwen BS. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res Rev 1994;19:1-28.
6. Armenteros JL, Adams PB, Campbell M, et al. Halopendol-related dyskinesias and pre- and perinatal complications in autistic children. Psychopharmacol Bull 1995;31:363-369.
7. Bachevalier J. Medial temporal lobe structures and autism: A review of clinical and experimental findings. Neuropsychologia 1994;32:627-648.
8. Bachevalier J. Brief report: Medial temporal lobe and autism: A putative animal model. J Autism Dev Disord 1996;26:217-220.
9. Baltaxe CA, Simmons JQ. Disorders of language in childhood psychoses. In: Darby J, ed. Speech Evaluation in Psychiatry. New York: Grune and Stratton, 1981, pp 285-328.
10. Baron-Cohen S. Do autistic children have obsessions and compulsions? Br J Clin Psychol 1989;28:193-200.
11. Bartak L, Rutter M. Differences between mentally retarded and normally intelligent autistic children. J Autism Child Schizophr 1996;6: 109-120.
12. Bauman, ML. Microscopic neuroanatomic abnormaliites in autism. Pediatrics 1991;87:791-796.
13. Baumeister AA, Todd ME, Sevin JA. Efficacy and specificity of pharmacological therapies for behavioral disorders in persons with mental retardation. Clin Neuropharmacol 1993;16: 271-294.
14. Bender L, Goldschmidt L, Sankar S. Treatment of autistic schizophrenic children with LSD-25 and UML-491 In: Wortis J, ed. Recent Advances in Biological Psychiatry. New York: Plenum Press, 1962:170-177.
15. Berkson G, Davenport RK. Stereotyped movements in mental defectives: 1. Initial survey. Am J Ment Defic 1962;66:849-852.
16. Bodfish JW, Madison JT. Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation. Am J Ment Retard 1993;98:360-367.
17. Bodfish JW, Crawford TW, Powell SB, et al. Compulsions in adults with mental retardation: Prevalence, phenomenology, and comorbidity with stereotypy and self-injury. Am J Ment Retard 1995a;100:183-192.
18. Bodfish JW, Powell SB, Golden RN, et al. Blink rate as an index of dopamine function in adults with mental retardation and repetitive behavior disorders. Am J Ment Retard 1995b;99: 335-344.
19. Bodfish JW, Newell KM, Sprague RL, et al. Dyskinetic movement disorder among adults with mental retardation: Phenomenology and co-occurrence with stereotypy. Am J Ment Retard 1996a;101:118-129.
20. th Gatlinburg Conference on Research and Theory in Mental Retardation, 1996b:142.
21. Bodfish JW, McCuller WR, Madison JM, et al. Placebo, double-blind evaluation of long term naltrexone treatment effects for adults with mental retardation and self-injury. J Dev Phys Disabil 1997a;9:135-152.
22. Bodfish JW, Newell KM, Sprague RL, et al. Akathisia in adults with mental retardation: Development of the Akathisia Ratings of Movement Scale (ARMS). Am J Ment Retard 1997b;101:413-423
23. Brasic JR., Barnett JY, Kaplan D, et al. Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation. Neurology 1994;44:1309-1312.
24. Brett LP, Levine S. Schedule-induced polydipsia and pituitary-adrenal activity in rats. J Comp Physiol Psychol 1979;93:946-956.
25. Burd L, Fisher WW, Kerbeshian J, et al. Is development of Tourette disorder a marker for improvement in patients with autistic and other pervasive developmental disorders? J Am Acad Child Adolesc Psychiatry 1987;26: 162-165.
26. Campbell M, Anderson LT, Meier M, et al. A comparison of haloperidol and behavior therapy and their interaction in autistic children. J Am Acad Child Psychiatry 1978;17: 640-655.
27. Campbell M, Adams P, Perry R, et al. Tardive and withdrawal dyskinesia in autistic children. Psychopharmacol Bull 1988;24:251-255.
28. Campbell M, Locascio J, Choroco B, et al. Stereorypies and tardive dyskinesia: Abnormal movements in autistic children. Psychopharmacol Bull 1990;26:260-266.
29. Castells S, Chakrabarti C, Winsberg BG, et al. Effects of L-5-hydroxytryptophan on monoamine and amino acid turnover in the Lesch-Nyhan syndrome. J Autism Dev Disord 1979;9:95-103.
30. Chadsey-Rusch J, Sprague RL. Maladaptive behaviors associated with neuroleptic drug maintenance. Am J Ment Retard 1989;93:607-617.
31. Charlop MH. Echolalia. In: Konarski E, Favell J, eds. Manual for the Assessment and Treatment of Behavior Disorders of People With Mental Retardation. Morganton, NC: WCC Foundation, 1992:1-13.
32. Comings D, Comings B. Clinical and genetic relationships between autism-pervasive developmental disorder and Tourette syndrome. AmJ Med Gen 1991;39:180-191.
33. Creese I, Iversen SD. Blockage of amphetamine-induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res 1973;55: 369-382.
34. Cronin G, Wiepkema P, Van Ree J. Endogenous opioids are involved in abnormal stereotyped behaviors of tethered sows. Neuropeptides 1985;6:527.
35. Curzon G. Stereotyped and other motor responses to 5-hydroxytryptamine receptor activation. In: Cooper SJ, Dourish CT, eds. Neurobiology of Stereotyped Behaviour. Oxford: Oxford University Press, 1990, pp 142-168.
36. Damasio A, Maurer R. A neurological model for childhood autism. Arch Neurol 1978;35: 777-786.
37. Dantzer R. Behavioral, physiological and functional aspects of stereotyped behavior: A review and re-interpretation. J Anim Sci 1986;62:1776-1786.
38. Ernst M, Zametkin AJ, Matochik JA, et al. Presynaptic dopanunergic deficits in Lesch-Nyhan disease. N Engl J Med 1996;334:1568-1572.
39. Fisch GS. Is autism associated with the fragile X syndrome? AmJ Med Gen 1992;43:47-55.
40. Freeman B, Ritvo E, Schroth P, et al. Behavioral characteristics of high and low IQ autistic children. Am J Psychiatry 1981;138:25-91.
41. Frith CD, Done DJ. Stereotyped behaviour in madness and in health. In: Cooper S, Dourish C, eds. Neurobiology of Stereotyped Behaviour. Oxford: Clarendon Press, 1990, pp 232-259.
42. Frith U. Studies in pattern detection in normal and autistic children: Reproduction and production of color sequences. J Exp Child Psychol 1970;10:120-135.
43. Frith U . Cognitive mechanisms in childhood autism: Experiments with color and tone sequence production. J Austism Child Schizophr 1972;2:160-172.
44. Giedd J, Rapoport J, Leonard H, et al. Case study: Acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy. J Am Acad Child Adolesc Psychiatry 1996;35: 913-915.
45. Gillberg C. Endogenous opioids and opiate antagonists in autism: Brief review of empirical findings and implications for clinicians. Dev Med Child Neurol 1995;37:239-245.
46. Goldstein M, Kuga S, Kusano N, et al. Dopamine agonist induced self-mutilating biting behavior in monkeys with unilateral ventromedial tegmental lesions of the brainstem: Possible pharmacological model for Lesch-Nyhan syndrome. Brain Res 1086;367:114-120.
47. Gordon CT, Rapoport JL, Hamburger SD, et al. Differential response of seven subjects with autistic disorder to clomipramine and desiprainine. Am J Psychiatry 1992;149:363-366.
48. Hagberg B, Aicardi J, Dias K, et al. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome. Ann Neural 1982;14:471-479
49. Hutt C, Hutt S. Stereotypies and their relation to arousal: A study of autistic children. In: Hutt S, Hutt C, eds. Behavior Studies in Psychiatry. Oxford: Pergamon Press, 1970, pp 175-204.
50. Iwamoto ET, Way EL. Circling behavior and stereotypy induced by intranigral opiate microinjection. J Pharmacol Exp Ther 1977;20:347-359.
51. Iwata B, Dorsey, M, Slifer K, et al. Toward a functional analysis of self-injury. Anal Interven Dev Disab 1982;2:3-20.
52. Kanner L. Autistic disturbances of affective content. Nervous Child 1943;2:217-250.
53. Kennes D, Odberg F, Bouquet Y et al. Changes in naloxone and haloperidol effects during the development of captivity-induced jumping stereotypy in bank voles. Eur J Pharmacol 1988;153:19-24.
54. Leonard H, Lenane, M, Swedo, S et al. Tics and Tourette's disorder: A 2- to 7- year follow-up of 54 obsessive-compulsive children. Am J Psychiatry 1992;149:1244-1251.
55. Lewis MH. Recent advances in pharmacotherapy. Curr Opin Psychiatry 1993;6:659-664.
56. Lewis MH. Psychopharmacology of autism spectrum disorders. J Autism Dev Disord 1996;26: 231-233.
57. Lewis MH, Baumeister AA. Stereotyped mannerisms in mentally retarded persons: Animal models and theoretical analyses. In: Ellis NR, ed. International Review of Research in Mental Retardation. Vol 11. New York: Academic Press, 1982, pp 123-161.
58. Lewis MH, Steer RA, Favell J, et al. Thioridazine metabolism and effects on stereotyped behavior in mentally retarded patients. Psychopharmacol Bull 1986;22:1040-1044.
59. Lewis MH, Baumeister AA, Mailman RB. A neurobiological alternative to the perceptual reinforcement hypothesis of stereotyped behavior: A commentary on "self-stimulatory behavior and perceptual reinforcement". J Appl Behav Anal 1987;20:253-258.
60. Lewis MH, Gluck JP, Beauchamp AJ, et al. Long-term effects of early social isolation in rhesus monkeys (Macaca mulatta): In vivo evidence for alterations in dopamine receptor sensitivity. Brain Res 1990;513:67-73.
61. Lewis MH, Bodfish JW, Powell SB, et al. Clomipramine treatment for stereotypy and related repetitive movement disorders associated with mental retardation. Am J Ment Retard 1995;100:299-312.
62. Lewis MH, Gluck JP, Bodfish JW et al. Neurobiological basis of stereotyped movement disorder in animals and humans. In: Sprague RL, Newell KM, eds. Stereotypy: Brain Behavior Relationships. Washington, DC: American Psychological Association Press, 1996a:37-67.
63. Lewis MH, Bodfish JW, Powell SB, et al. Plasma HVA in adults with mental retardation and stereotyped behavior: Biochemical evidence for a dopamine deficiency model. Am J Ment Retard 1996b;100:413-427.
64. Lewis MH, Bodfish JW, Powell SB, et al. Clomipramine treatment for self-injurious behavior in individuals with mental retardation: A double-blind comparison with placebo. AmJ Ment Retard 1996c;100:654-665.
65. Lloyd KG, Hornykiewicz O, Davidson L et al. Biochemical evidence of dysfunction of bnrain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med 1981;305:1106-1111.
66. Lovaas I, Schreibman L. Stimulus overselectivity of autistic children in a two stimulus situation. Behav Res Ther 1971;9:305-310.
67. Lovaas I, Newsom C, Hickman C. Self-stimulatory behavior and perceptual reinforcement. J Appl Behav Analysis 1987;20:45-68.
68. Malkova L, Mishkin M, Suomi S, et al. Socioemotional behavior in adult rhesus monkeys after early versus late lesions of the medial temporal lobe. Ann NY Acad Sci 1997;807:538-540.
69. Martin L, Spicer DW, Lewis MH et al. Social deprivation in infant rhesus monkeys alters the chemoarchitecture of the brain: I. Subcortical regions. J Neurosurg 1991;11:3344-3358.
70. Mason G. Stereotypies: A critical review. Anim Behav 1991;41:1015-1037.
71. Matson J, Baglio C, Smiroldo B, et al. Characteristics of autism as assessed by the diagnostic Assessment for the Severely Handicapped-II (DASH-II). Res Dev Disab 1996;17:135-143.
72. McDougle C, Kresch L, Goodman W, et al. A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. Am J Psychiatry 1995;152:727-777.
73. McDougle C, Naylor S, Cohen D, et al. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996;53:1001-1008.
74. McDougle C, Naylor S, Cohen D, et al. Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 1996;53: 993-1000.
75. McDougle CJ, Price LH, Volkmar FR, et al. Clomipramine in autism: preliminary evidence of efficacy. J Am Acad Child Adolesc Psychiatry 1992;31:746-750.
76. Meiselas K, Spencer E, Oberfield R, et al. Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children. J Clin Psychopharm 1989;9:207-209.
77. Mittleman G, Jones GH, Robbins TW. Sensitization of amphetamine stereotypy reduces plasma corticosterone: Implications for stereotypy as a coping response. Behav Neural Biol 1991;56:170-183.
78. Moodley M. Treatment of Rett's syndrome with bromocriptine. South Afr Med J 1993;83:138.
79. Odberg F, Kennes D, DeRycke PH, et al. The effect of interference in catecholamine biosynthesis on captivity-induced jumping stereotypy in bank voles (Clethrionomys glareolus). Arch Int Pharmacodyn 1987;285:34-42.
80. Ornitz EM. Childhood autism: A disorder of sensorimotor integration. In: Rutter M, ed. Infantile Autism: Concepts, Characteristics, and Treatment. London: Churchill Livingstone, 1971.
81. O'Sullivan R, Rauch S, Breiter H, et al. Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry 1997;42:39-45.
82. Owens D, Johnstone E, Frith C. Spontaneous involuntary disorders of movement. Arch Gen Psychiatry 1982;39:452-416.
83. Pauls D, Towbin K, Leckman J. Gilles de la Tourette's syndrome and obsessive-compulsive disorder: Evidence supporting a genetic relationship. Arch Gen Psychiatry 1986;43: 1180-1182.
84. Powell S, Bodfish J, Parker D, et al. Self-restraint and self-injury: Occurrence and motivational significance. Am J Ment Retard 1996;101:41-48.
85. Powell S, Wechsler E, Newman H, et al. Behavioral and biochemical effects of chronic fluoxetine treatment in an animal model of repetitive behavior disorder. Soc Neurosci Abstr 1997; 23:802.
86. Prior M, MacMillan M. Maintenance of sameness in children with Kanner's Syndrome. J Autism Child Schizophr 1973;3:154-167.
87. Prizant B, Duchan J. The functions of immediate echolalia in autistic children. J Speech Hear Dis 1981;46:241-249.
88. Rapoport JL. The neurobiology of obsessive-compulsive disorder [clinical conference] JAMA 1988;260:2888-2890.
89. Rasmussen S, Eisen J. Phenomenology of OCD. In: Zohar J, Insel T, Rasmussen S, eds. Psychobiology of Obsessive-Compulsive Disorder. New York: Springer, 1991:13-93.
90. Ridley RM. The psychology of perseverative and stereotyped behaviour. Prog Neurobiol 1994; 44:221-231.
91. Robbins TW, Koob GF. Selective disruption of displacement behaviour by lesions of the mesolimbic dopamine system. Nature 1980; 285:409-412
92. Rutter M. The treatment of autistic children Child Psychol Psychiatry 1985;26:193-214.
93. Rutter M. Autism research: Prospects and priorities. J Autism Dev Disord 1996;26:257-275.
94. Sachdev P, Loneragan C. The present status of akathisia. J Nerv Ment Dis 1991;179:381-391.
95. Sandman C, Hetrick W. Opiate mechanisms in self-injury. Ment Retard Dev Disab Res Rev 1995;1:130-136.
96. Sandman CA, Barron JL, Coleman H. An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior. Am J Ment Retard 1990;95:93-102.
97. Scheel-Kruger J, Amt J, Braestrup C, et al. GABA-dopamine interactions in substantia nigra and nucleus accumbens - relevance to behavioral stimulation and stereotyped behavior. In: Roberts PJ, Woodruff GN, Iversen LL,eds. Advances in Biochemical Pharmacology. vol 19. New York: Raven Press, 1978, pp 343-346.
98. Scheel-Kruger J, Arnt J, Magelund G, et al. Behavioral functions of GABA in basal ganglia and limbic system. Brain Res Bull 1980;5:261-267.
99. Schroeder S, Schroeder C, Smith B, et al. Prevalence of self-injurious behavior in a large state fecility for the retarded. J Autism Child Schizophr 1978;8:261-269.
100. Shay J, Sanchez L, Cueva J, et al. Neuroleptic-related dyskinesia and stereotypies in autistic children. Psychopharm Bull 1993;29:359-363.
101. Simmons J, Leiken S, Lovaas OI, et al. Modification of autistic behavior with LSD-25. Am J Psychiatry 1966;1201-1211.
102. Simon-Soret C, Borenstein P. Essai de la bromocripnne dans le traitment de l'autisme infantile-Presse Med 1987;16:1286.
103. Sivam S. GBR-12909-induced self-injurious behavior: Role of dopamine. Brain Res 1995;690: 259-263.
104. Sprague R, Korach M, van Emmerick R, et al. Correlations between kinematic and rating scale measures of tardive dyskinesia in a developmentally disabled population. J Nerv Ment Dis 1993;181:42-47.
105. Suomi SJ, Harlow HF. Abnormal social behavior in young monkeys. In: Hellmuth J, ed. The Exceptional Infant. vol 2 New York: Bruner-Mazel, 1971.
106. Swedo S, Leonard H, Rapoport J. Childhood-onset obsessive compulsive disorder. Psychiatr Clin North Am 1992;15:767-775.
107. Teitlebaum P, Maurer R, Fryman J, et al. Dimensions of disintegration in the stereotyped locomotion characteristic of parkinsonism and autism. In: Sprague RL, Newell KM, eds. Stereotypy: Brain Behavior Relationships. Washington, DC: American Psychological Association Press, 1996:167-193.
108. Thompson T, Hackenburg T, Cerutti D, et al. Opioid antagonist effects on self-injury in adults with mental retardation: Response form and location as determinants of medication effects. Am J Ment Retard 1994;99:85-102.
109. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand 1971;367:1-48.
110. Vilensky J, Damasio A, Maurer R. Gait disturbances in patients with autistic behavior. Arch Neurol 1981;38:646-649.
111. Wayner MJ, Mintz RB, Jolicoeur FB, et al. Effects of methylphenidate on schedule dependent and schedule-induced behavior. Pharmacol Biochem Behav 1979;10:299-302.
112. Wong DF, Harris JC, Naidu S, et al. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci USA 1996;93:5539-5543.
113. Wright M, Hewlett W. Neurobiology of obsessive compulsive disorder. Comp Ther 1994;20:95-100.
114. Young R, Weigner A. Tremor. In: Swash M, Kennard C, eds. Scientific Basis of Clinical Neurology. Edinburgh: Churchill Livingstone, 1985:116-132.
115. Zappella M, Genazzani A. Girls with Rett syndrome treated with bromocriptine. Wien Klin Wochenschr 1986;98.22.